Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

NCT03229746 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03229746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03229746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia
Lead sponsor
Assiut University
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2017
Completion date
June 1, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia